Results 1 to 10 of about 679,466 (304)

Chronotropic incompetence in end-stage liver disease.

PLoS ONE, 2022
BackgroundCirrhosis causes alterations in the cardiovascular and autonomic nervous systems and leads to cirrhotic cardiomyopathy (CCM). CCM is defined as cardiac dysfunction characterized by an impaired systolic responsiveness to stress or exercise, and ...
Renata Główczyńska, Sonia Borodzicz-Jażdżyk, Michał Peller, Joanna Raszeja-Wyszomirska, Piotr Milkiewicz, Krzysztof Zieniewicz, Grzegorz Opolski   +6 more
doaj   +4 more sources

Opportunistic infections in end stage liver disease

Infectious Disease Reports, 2018
Liver cirrhosis is the 10th most common cause of death in Western world and infection is associated with a high morbidity and mortality, and represents the leading cause of acute liver decompensation.
Michele Bartoletti, Maddalena Giannella, Sara Tedeschi, Pierluigi Viale   +3 more
doaj   +4 more sources

Association of mild-to-moderate Model for End-Stage Liver Disease scores on short-term cardiac surgery postoperative outcomesCentral MessagePerspective [PDF]

JTCVS Open
Objective: We assessed the Model for End-Stage Liver Disease score in patients with mild-moderate scores to predict perioperative outcomes in patients undergoing cardiac surgery.
Tom Liu, MD, MS, Zhanlin Chen, BS, MS, Ryan C. Jacobs, MD, MS, Charles D. Logan, MD, MS, Beth Whippo, MSN, RN, Seokyung An, PhD, Patrick M. McCarthy, MD, Christopher K. Mehta, MD   +7 more
doaj   +2 more sources

Evaluation of correlation between etiology of end stage liver disease and intraoperative utilization of blood products during liver transplantation [PDF]

Saudi Journal of Anaesthesia
Background: Liver transplantation is frequently associated with massive blood loss and utilization of blood products to optimize coagulation; this study aimed to evaluate their possible correlation with etiological and perioperative factors.
Amer Majeed, Basel A. Jobeir, Muhammad Shabbir, Mohammed Ibrahim, Mohamad S. Nagy, Bilal Tufail, Dimitri A. Raptis, Luluah Altukhaifi, Areej A. G. AlFattani   +8 more
doaj   +2 more sources

Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea [PDF]

The Korean Journal of Internal Medicine
Background/Aims The model for end-stage liver disease (MELD) serves as an indicator for short-term mortality among patients diagnosed with liver cirrhosis (LC) and is used to prioritize patients for liver transplantation.
Jeong Han Kim, Yong Joon Cho, Won Hyeok Choe, So Young Kwon, Byung-Chul Yoo   +4 more
doaj   +2 more sources

Palliative Care in End-Stage Liver Disease

Livers
Chronic liver disease is a significant global cause of morbidity and mortality. While early-stage liver cirrhosis is often asymptomatic, it can progress to a decompensated phase known as end-stage liver disease (ESLD), resulting in a high symptom burden,
Luisa Sousa, Sofia Marques Silva, Francisca Rego, Rui Nunes, Hugo M. Oliveira   +4 more
doaj   +2 more sources

Evaluation of the correlation between six scoring systems for assessing the severity of end-stage liver disease and intraoperative blood loss during liver transplantation: a retrospective study [PDF]

Clinical Transplantation and Research
Background : Patients with end-stage liver disease (ESLD) are particularly susceptible to intraoperative hemorrhage during liver transplantation (LT), a risk partly attributable to coagulopathy.
Amer Majeed, Noon E Abdelgadir, Momina Amer, Muhammad Shabbir, Mohammed Ibrahim, Mohamad S Nagy, Bilal Tufail, Luluah Altukhaifi, Areej A G AlFattani   +8 more
doaj   +2 more sources

Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease [PDF]

BMC Gastroenterology
Background and aims Intestinal paralysis is a common complication in end-stage liver disease (ESLD), our aim is to assess the effectiveness and safety of low-dose terlipressin for treating intestinal paralysis in ESLD.
Xia Wan, Hua Xu, Hu Li, Shan Zhong, Yu Lei, Huan Deng, Xiao Fu, Zhi Zhou   +7 more
doaj   +2 more sources

Model for End-stage Liver Disease [PDF]

Journal of Clinical and Experimental Hepatology, 2013
Model for end-stage liver disease (MELD) score, initially developed to predict survival following transjugular intrahepatic portosystemic shunt was subsequently found to be accurate predictor of mortality amongst patents with end-stage liver disease.
Ashwani K, Singal, Patrick S, Kamath
openaire   +3 more sources

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease

Biomolecules, 2021
Liver transplantation is the only curative option for end-stage liver disease; however, the limitations of liver transplantation require further research into other alternatives.
Yan Li, Lungen Lu, Xiaobo Cai
doaj   +1 more source